The Ministry of Health gives the green light to the first drug that slows the progression of ALS.

ALS is considered a rare disease—it affects around 400 people in Catalonia—but it progresses very rapidly and is highly debilitating. — File image of a person with ALS. GETTY

1 min

The Ministry of Health approved this Thursday the funding of Tofersen, an innovative therapy for amyotrophic lateral sclerosis (ALS) that helps preserve neuronal function and slow the progression of the disease. The European Medicines Agency (EMA) approved the drug a year ago.

The Ministry of Health gives the green light to the first drug that slows the progression of ALS.

Execution in broad daylight in Castelldefels: three shots fired at a man from Montenegro

The NBA lands in Europe: a farce or a historic opportunity?

The University of Barcelona (UB) has filed another complaint against the CREA research group with the Public Prosecutor's Office and has suspended two employees and another professor.

Sánchez chooses Elma Saiz as the new spokesperson for the Spanish government

This is the unofficial Aliança chat: xenophobia and the CUP in the crosshairs

Less stress, more celebration: Mercadona's tips for an easy and successful Christmas

Segura Viudas: three cavas to celebrate Christmas with style and tradition

The promotion and development of affordable housing

The promotion and development of affordable housing in Catalonia

Barcelona's cultural power is on full display at the Guadalajara International Book Fair